G1 Therapeutics Inc [NASDAQ: GTHX] stock went on a downward path that fall over 0.00% on Monday, amounting to a one-week price increase of more than 0.14%.
Over the last 12 months, GTHX stock rose by 346.88%. The one-year G1 Therapeutics Inc stock forecast points to a potential downside of 0.0. The average equity rating for GTHX stock is currently 3.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $377.23 million, with 51.93 million shares outstanding and 43.27 million shares in the current float. Compared to the average trading volume of 2.13M shares, GTHX stock reached a trading volume of 5246739 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on G1 Therapeutics Inc [GTHX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GTHX shares is $7.15 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GTHX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for G1 Therapeutics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 30, 2023. While these analysts kept the previous recommendation, Needham dropped their target price from $32 to $31. The new note on the price target was released on January 03, 2023, representing the official price target for G1 Therapeutics Inc stock. Previously, the target price had yet another drop from $20 to $19, while JP Morgan kept a Underweight rating on GTHX stock.
The Average True Range (ATR) for G1 Therapeutics Inc is set at 0.09, with the Price to Sales ratio for GTHX stock in the period of the last 12 months amounting to 6.48. The Price to Book ratio for the last quarter was 15.32, with the Price to Cash per share for the same quarter was set at 1.15.
GTHX Stock Performance Analysis:
G1 Therapeutics Inc [GTHX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.14. With this latest performance, GTHX shares gained by 0.70% in over the last four-week period, additionally plugging by 129.90% over the last 6 months – not to mention a rise of 346.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GTHX stock in for the last two-week period is set at 84.40, with the RSI for the last a single of trading hit 84.36, and the three-weeks RSI is set at 81.57 for G1 Therapeutics Inc [GTHX]. The present Moving Average for the last 50 days of trading for this stock 5.57, while it was recorded at 7.14 for the last single week of trading, and 4.01 for the last 200 days.
Insight into G1 Therapeutics Inc Fundamentals:
G1 Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.12 and a Current Ratio set at 2.48.
G1 Therapeutics Inc [GTHX] Institutonal Ownership Details
There are presently around $54.28%, or 60.94%% of GTHX stock, in the hands of institutional investors. The top three institutional holders of GTHX stocks are: BLACKROCK INC. with ownership of 3.08 million shares, which is approximately 5.9075%. VANGUARD GROUP INC, holding 2.49 million shares of the stock with an approximate value of $$5.68 million in GTHX stocks shares; and VANGUARD GROUP INC, currently with $$3.11 million in GTHX stock with ownership which is approximately 2.6113%.
